BEAM 8-K 2026-01-12

Beam Therapeutics Inc. (BEAM) 8-K dated 2026-01-12 — accession 0001193125-26-009722. This URL is the filing, not the BEAM hub.

Beam Therapeutics Inc. (BEAM) is a biotechnology company listed on US.

Beam Therapeutics Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009722.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BEAM revenue for 2025-12-31 was $139.7M. Net income was -$80.0M. BEAM currently screens at market cap $2.01B.

Not investment advice. The BEAM SEC hub lists recent forms. The stock page is the research view.